|
CN111825749A
|
|
Anti-tumor polypeptide and preparation method and application thereof
|
|
CN111875673A
|
|
Polypeptide with anti-tumor activity and application thereof
|
|
CN111838134A
|
|
Tumor tissue transfer liquid and application
|
|
CN111876384A
|
|
Tumor tissue implantation liquid and preparation method and application thereof
|
|
CN111705065A
|
|
anti-KRAS mutant monoclonal antibody and application thereof
|
|
CN111763255A
|
|
Genetically modified VEGFA protein, monoclonal antibody thereof and application
|
|
CN111733162A
|
|
Genetically modified CD47 protein, monoclonal antibody thereof and application
|
|
CN111778257A
|
|
Genetically modified CD96 protein, monoclonal antibody thereof and application
|
|
CN111705066A
|
|
Genetically modified TIGIT protein, monoclonal antibody and application thereof
|
|
CN111253483A
|
|
anti-BRCA 1 monoclonal antibody and application thereof
|
|
CN110684105A
|
|
anti-HSP 90 monoclonal antibody and kit
|
|
CN109580959A
|
|
A kind of ELISA kit detecting heparin-binding epidermal growth factor
|
|
CN109535252A
|
|
A kind of anti-HB-EGF monoclonal antibody and preparation method thereof
|
